‌

US Patent 8846040 Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Patent 8846040 was granted and assigned to Rani Therapeutics on September, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Rani Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8846040

Patent Inventor Names

Mir Imran0

Date of Patent

September 30, 2014

Patent Application Number

13539031

Date Filed

June 29, 2012

Patent Citations Received

‌

US Patent 12064520 Components with high API loading

‌

US Patent 11833319 Propulsive drug delivery from a swallowable device into a patients intestinal tract

‌

US Patent 11872396 Swallowable capsule and method for stimulating incretin production within the intestinal tract

‌

US Patent 12018090 PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

‌

US Patent 12059562 Systems for electrical stimulation

‌

US Patent 11654182 Method of delivering gonadotropin releasing hormone or an analogue thereof into a lumen of the intestinal tract using a swallowable drug delivery device

‌

US Patent 11684761 Preparation comprising exanatide for delivery into a lumen of the intestinal tract

‌

US Patent 11712421 Self-actuating articles

...

Patent Primary Examiner

‌

Gyan Chandra

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8846040 Therapeutic agent preparations comprising etanercept for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API